NCT00036127View on ClinicalTrials.gov

Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders

PHASE2/PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2002

Primary Completion Date

January 31, 2003

Study Completion Date

January 31, 2003

Conditions
Schizophrenia
Interventions
DRUG

aripiprazole

Trial Locations (16)

Unknown

Local Institution, Anaheim

Local Institution, Cerritos

Local Institution, Chula Vista

Local Institution, Rosemead

Local Institution, San Diego

Local Institution, Atlanta

Local Institution, Macon

Local Instituton, Hoffman Estates

Local Institution, Las Vegas

Local Institution, Nashua

Local Institution, New York

Local Institution, Beachwood

Local Institution, Philadelphia

Local Institution, Charleston

Local Institution, Houston

Local Institution, Milwaukee

All Listed Sponsors
lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT00036127 - Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders | Biotech Hunter | Biotech Hunter